Natera, Inc. (NTRA)
209.53
+0.18
(+0.09%)
USD |
NASDAQ |
Feb 24, 16:00
209.55
+0.02
(+0.01%)
After-Hours: 20:00
Natera Research and Development Expense (Quarterly) : 173.41M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| EXACT Sciences Corp. | 191.50M |
| Illumina, Inc. | 238.00M |
| Guardant Health, Inc. | 98.26M |
| GeneDx Holdings Corp. | 24.03M |
| Delcath Systems, Inc. | 7.986M |